Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Equity (2019 - 2025)

Historic Return on Equity for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to 0.42%.

  • BridgeBio Pharma's Return on Equity rose 300.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.39% for FY2024, which is 1200.0% down from last year.
  • As of Q3 2025, BridgeBio Pharma's Return on Equity stood at 0.42%, which was up 300.0% from 0.44% recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Return on Equity ranged from a high of 4.09% in Q1 2021 and a low of 0.39% during Q4 2024
  • Moreover, its 5-year median value for Return on Equity was 0.49% (2023), whereas its average is 0.76%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 47600bps in 2021, then plummeted by -34200bps in 2022.
  • BridgeBio Pharma's Return on Equity (Quarter) stood at 0.78% in 2021, then crashed by -36bps to 0.49% in 2022, then rose by 7bps to 0.53% in 2023, then decreased by -26bps to 0.39% in 2024, then rose by 7bps to 0.42% in 2025.
  • Its Return on Equity stands at 0.42% for Q3 2025, versus 0.44% for Q2 2025 and 0.42% for Q1 2025.